1. Home
  2. RCEL vs DUOT Comparison

RCEL vs DUOT Comparison

Compare RCEL & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • DUOT
  • Stock Information
  • Founded
  • RCEL N/A
  • DUOT 1990
  • Country
  • RCEL United States
  • DUOT United States
  • Employees
  • RCEL N/A
  • DUOT N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • RCEL Health Care
  • DUOT Technology
  • Exchange
  • RCEL Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • RCEL 140.5M
  • DUOT 125.8M
  • IPO Year
  • RCEL N/A
  • DUOT N/A
  • Fundamental
  • Price
  • RCEL $5.33
  • DUOT $8.89
  • Analyst Decision
  • RCEL Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • RCEL 4
  • DUOT 2
  • Target Price
  • RCEL $13.75
  • DUOT $12.75
  • AVG Volume (30 Days)
  • RCEL 267.6K
  • DUOT 264.9K
  • Earning Date
  • RCEL 11-06-2025
  • DUOT 11-18-2025
  • Dividend Yield
  • RCEL N/A
  • DUOT N/A
  • EPS Growth
  • RCEL N/A
  • DUOT N/A
  • EPS
  • RCEL N/A
  • DUOT N/A
  • Revenue
  • RCEL $74,884,000.00
  • DUOT $15,387,935.00
  • Revenue This Year
  • RCEL $22.92
  • DUOT $294.36
  • Revenue Next Year
  • RCEL $37.07
  • DUOT $52.93
  • P/E Ratio
  • RCEL N/A
  • DUOT N/A
  • Revenue Growth
  • RCEL 38.32
  • DUOT 172.93
  • 52 Week Low
  • RCEL $3.60
  • DUOT $3.40
  • 52 Week High
  • RCEL $14.16
  • DUOT $9.60
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 49.55
  • DUOT 68.12
  • Support Level
  • RCEL $5.14
  • DUOT $8.36
  • Resistance Level
  • RCEL $5.61
  • DUOT $9.60
  • Average True Range (ATR)
  • RCEL 0.24
  • DUOT 0.53
  • MACD
  • RCEL -0.03
  • DUOT 0.10
  • Stochastic Oscillator
  • RCEL 41.94
  • DUOT 69.00

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: